INTERVIEW
CEO Tom Englund on his insights into simulation and the medtech industry.
Leading Position in a Global Niche Market
Surgical Science is a medical simulation company – with core competence around its proprietary software and hardware for the simulation of instrument/tissue interactions. Based on its own technology, turnkey simulators are developed, manufactured, and sold to teaching hospitals, clinics, and medical training centers. More than 8,000 systems have been delivered worldwide supported by more than 400 validation studies. In parallel with its own products, Surgical Science also provides medical technology companies with device-specific simulation solutions.
Surgical Science has successfully over the years acquired simulation companies Simbionix, Mimic Technologies, SenseGraphics and Intelligent Ultrasound to form a world-leading simulation company. The company is listed on Nasdaq First North Growth Market in Stockholm, Sweden.
Presentation of Interim Report Q1 | May 14, 2025
Financial Reports
This section lists all available financial information about Surgical Science Sweden AB, listed on Nasdaq First North Growth Market in Stockholm.
Press Releases
For press releases before 2021, please refer to the Swedish page.
-
2025-05-15
-
2025-05-14
-
2025-05-05
-
2025-04-14
-
2025-04-14
-
2025-02-19
-
2025-02-18
-
2025-02-06
-
2025-02-04
-
2025-02-04
-
2025-02-03
-
2025-01-15
-
2025-01-15
Press Release Subscription
Calendar
Owner list
Owner Concentration
Country Distribution
Owner Holding Distribution
IR Contact
Anna Ahlberg
Adele Horn
The Company’s Certified Adviser
DNB Carnegie Investment Bank AB
Phone: +46 (0)73 856 42 65
E-mail: certifiedadviser@carnegie.se